A phase II study of BAY 43-9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal cancer (NPC). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Siu, LL
  • Winquist, E
  • Agulnik, M
  • Chin, SF
  • Pond, Gregory
  • Cheiken, R
  • Francis, P
  • Petrenciuc, O
  • Chen, E

publication date

  • June 1, 2005